On November 14, GUOQUAN (02517) spent 6.4799 million Hong Kong dollars to repurchase 3.18 million shares.

14/11/2024

GMT Eight

GUOQUAN (02517) announced that on November 14, 2024, the company spent 6.4799 million Hong Kong dollars to repurchase 3.18 million shares at a repurchase price of 2.02-2.05 Hong Kong dollars per share.

SINO BIOPHARM (01177): Fourth generation EGFR inhibitor "TQB3002" granted permission for clinical trials in the United States.

Bilibili (09626) releases its Q3 financial report for 2024: Achieves profitability for the first time in a single quarter, with community engagement reaching a record high.

Contact: contact@gmteight.com

On November 14, GUOQUAN (02517) spent 6.4799 million Hong Kong dollars to repurchase 3.18 million shares.

RECOMMEND

Be wary of the tariff war and declining demand! Goldman Sachs lowers its copper price target to $8,500.

New share prospects | Four-pronged approach to meet the "Red Sea" competition, has Subao International shaken off growth anxiety?

Hedge funds' Q3 new trend: reducing holdings in technology stocks.